Skip to content

Clinical Study on Tuina Therapy for Lower Limb Muscle Dysfunction in Spleen-Kidney Deficiency Type Sarcopenia

Clinical Study on Tuina Therapy for Lower Limb Muscle Dysfunction in Spleen-Kidney Deficiency Type Sarcopenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001553
Enrollment
Unknown
Registered
2026-06-20
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

Treatment group:Routine rehabilitation exercises + tuina techniques

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Middle-aged and elderly individuals aged 50-75 years, with no restriction on gender. (2) Participants with a Short Physical Performance Battery (SPPB) score =9 points. (3) Participants meeting the criteria for skeletal muscle mass index (ASMI): for men aged 50-64 years, ASMI <7.2 kg/m²; for women aged 50-64 years, ASMI <5.5 kg/m²; for men aged 65 years and older, ASMI <7.0 kg/m²; and for women aged 65 years and older, ASMI <5.4 kg/m². (4) Participants meeting the diagnostic criteria for traditional Chinese medicine (TCM) syndrome differentiation. (5) Patients who have signed the informed consent form, voluntarily participate in this study, and are able to cooperate with the research. (6) Patients with normal cognitive function who can communicate and interact normally with researchers. (7) Participants who are able to complete questionnaires independently or with assistance.

Exclusion criteria

Exclusion criteria: (1) Other chronic wasting diseases leading to sarcopenia, such as severe malnutrition; severe chronic obstructive pulmonary disease (COPD), severe chronic kidney disease (eGFR < 30), severe diabetes, cirrhosis, severe fatty liver disease, or other diseases or physiological conditions that may affect muscle mass. (2) Individuals who may develop disuse muscle atrophy or any severe injuries or diseases significantly affecting gait, such as those who have experienced lower limb or pelvic fractures in the past 12 months, resulting in inability to bear weight and walk; or those with hemiplegia, myasthenia gravis, severe Parkinson's disease, peripheral neuropathy, advanced peripheral vascular disease with intermittent claudication, spinal stenosis, or severe osteoarthritis of the knee or hip with pain management ineffective, impacting lower limb mobility. (3) Individuals with conditions unsuitable for massage or exercise, such as local skin infections or severe skin edema. (4) History of joint replacement surgery or amputation. (5) History of mental disorders, language and emotional communication disorders, or other neurological diseases. (6) Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Short physical performance battery,SPPB;

Secondary

MeasureTime frame
Timed up and go,TUG;Berg balance scale,BBS;Total Symptom Score in Traditional Chinese Medicine and Syndrome Efficacy Assessment;

Countries

China

Contacts

Public ContactShuaipan Zhang

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

18939061729@163.com18939061729

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026